ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Kelsee Dienogest 2 mg/ 0.02 mg Ethinylestradiol, Retardtabletten - 28
69616001 Exeltis Suisse SA
Kelsee Dienogest 2 mg/ 0.02 mg Ethinylestradiol, Retardtabletten13.08.2025
  13.08.2025
Dienogest and Ethinylestradiol (G03AA16) 
WHO-DDD12.08.2030
28
09.02.10. 
B  
No 
IPCI
   
k.A. 
  
7680696160016Synthetika
  
Composition
I) weisse Retardtablette: dienogestum 2 mg, ethinylestradiolum 0.02 mg, lactosum monohydricum 19.48 mg, hypromellosum, povidonum K 30, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, pro compresso. II) runde, grüne, Placebo-Retardtablette: lactosum monohydricum 55.5 mg, maydis amylum, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, triacetinum, polysorbatum 80, E 171, E 132, E 172 (flavum), pro compresso.
Packungsbestandteile
I
Delayed release tablets
 
Active AgentDose
Dienogestum2 mg
Ethinyl Estradiol0.02 mg
 
Inactive agentsDoseadditional_information
E 171 color.
Hypromellosum  
Lactose Monohydrate19.48 mg 
Macrogol3350  
Magnesii Stearas  
Poly(Alcohol Vinylicus) Überzug
Povidonum K30  
Pro Compresso  
Talcum  
II
Delayed release tablets
  
 
Inactive agentsDoseadditional_information
(Flavum)  
E 132 color.
E 171 color.
E 172 color.
Grüne  
Hypromellosum Überzug
Lactose Monohydrate55.5 mgPlacebo-Retardtablette
Magnesii Stearas  
Maydis Amylum  
Polysorbatum 80  
Povidonum K30  
Pro Compresso  
Runde  
Silica Colloidalis Anhydrica  
Triacetinum  
Source
Data was imported : 03.09.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | Login | Contact | Home